Form 8-K - Current report:
SEC Accession No. 0001437749-25-030719
Filing Date
2025-10-08
Accepted
2025-10-08 16:33:30
Documents
15
Period of Report
2025-10-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20251008_8k.htm   iXBRL 8-K 32884
2 EXHIBIT 99.1 ex_867784.htm EX-99.1 29410
7 logosmlr.jpg GRAPHIC 3845
  Complete submission text file 0001437749-25-030719.txt   207823

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crvo-20251008.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20251008_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20251008_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20251008_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT crvo20251008_8k_htm.xml XML 2829
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 251382678
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)